Author:
Miller Joanna L.,Lachica Ruben,Sayce Andrew C.,Williams James P.,Bapat Manisha,Dwek Raymond,Beatty P. Robert,Harris Eva,Zitzmann Nicole
Abstract
ABSTRACTA key challenge faced by promising antiviral drugs, such as iminosugars, isin vivodelivery to achieve effective levels of drug without toxicity. Four iminosugars, all deoxynojirimycin (DNJ) derivatives—N-butyl DNJ (NB-DNJ),N-nonyl DNJ,N-(9-methoxynonyl) DNJ, andN-(6′-[4″-azido-2″-nitrophenylamino]hexyl)-1-DNJ (NAP-DNJ)—potently inhibited both the percentage of cells infected with dengue virus and release of infectious virus from primary human monocyte-derived macrophages, demonstrating their efficacy in primary cells. In a lethal antibody-dependent enhancement mouse model of dengue pathogenesis, freeNB-DNJ significantly enhanced survival and lowered viral load in organs and serum. Liposome-mediated delivery ofNB-DNJ, in comparison with freeNB-DNJ, resulted in a 3-log10reduction in the dose of drug sufficient to enhance animal survival. The optimizing of the effective dose in this way could liberate the therapeutic potential of many cytotoxic antivirals against both dengue virus and a wide array of other viruses.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献